Skip to main content
SpringerLink
Log in

Iperprolattinemia da psicofarmaci: problemi di gestione diagnostica e terapeutica

  • IPOTALAMO-IPOFISI
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Bibliografia

  1. Grigg J, Worsley R, Thew C, Gurvich C, Thomas N, Kulkarni J (2017) Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research. Psychopharmacology 234(22):3279–3297. https://doi.org/10.1007/s00213-017-4730-6. Epub 2017 Sep 9

    Article  CAS  PubMed  Google Scholar 

  2. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(2):273–288

    Article  CAS  PubMed  Google Scholar 

  3. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T (2006) Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatr 21(4):251–258. Epub 2006 Mar 10

    Article  Google Scholar 

  4. Bitter I, Basson BR, Dossenbach MR (2005) Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol 20(1):19–21

    Article  PubMed  Google Scholar 

  5. Cavallaro R, Cocchi F, Angelone SM, Lattuada E, Smeraldi E (2004) Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study. J Clin Psychiatry 65(2):187–190

    Article  CAS  PubMed  Google Scholar 

  6. Froes Brandao D, Strasser-Weippl K, Goss PE (2016) Prolactin and breast cancer: the need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: a review. Cancer 122(2):184–188. https://doi.org/10.1002/cncr.29714. Epub 2015 Oct 12

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Mediche, Divisione di Endocrinologia, Diabetologia e Metabolismo, Città della Salute e della Scienza di Torino, Università of Torino, Torino, Italia

    Nunzia Prencipe & Silvia Grottoli

Authors
  1. Nunzia Prencipe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia Grottoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nunzia Prencipe.

Ethics declarations

Conflitto di interesse

Le Autrici dichiarano di non avere conflitti di interesse.

Silvia Grottoli dichiara che negli ultimi 5 anni ha avuto rapporti anche di finanziamento con i seguenti soggetti portatori di interessi commerciali in campo sanitario: Janssen-Cilag.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prencipe, N., Grottoli, S. Iperprolattinemia da psicofarmaci: problemi di gestione diagnostica e terapeutica. L'Endocrinologo 20 (Suppl 1), 30–33 (2019). https://doi.org/10.1007/s40619-019-00561-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-019-00561-w

Search

Navigation